Metabolic Viral Host Properties
NCT00893308 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-05-12
Summary
Patients' metabolic properties may affect their immune response. This study aims to assess the effect of hosts' metabolic properties to viral infection.
Conditions
- HCV Infection
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
More Related Trials
-
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1
NCT00790673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
NCT06508996 ·Status: COMPLETED
-
Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases
NCT06829966 ·Status: COMPLETED
-
MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)
NCT00857311 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects
NCT00663208 ·Status: COMPLETED ·Phase: PHASE2
-
Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT
NCT00294489 ·Status: UNKNOWN
-
The Metabolic Profile and Adipocytokine Alterations of Patients With HCV Infection Before and After HCV Therapy
NCT01360268 ·Status: UNKNOWN
-
Racial Difference in HCV/Host Interactions
NCT00071916 ·Status: COMPLETED
-
Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)
NCT01508156 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Immune Response to Hepatitis C Virus
NCT00237432 ·Status: COMPLETED
-
Very Rapid and Rapid Virological Response as Predictors of Response of HCV Tretment
NCT03480269 ·Status: UNKNOWN
-
HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
NCT01293279 ·Status: COMPLETED
-
Study on Immunopathogenesis in HIV and Hepatitis C Coinfection
NCT01296529 ·Status: COMPLETED
-
Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects
NCT01459419 ·Status: UNKNOWN ·Phase: PHASE2
-
Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C
NCT00322179 ·Status: COMPLETED
-
MMF Influence on HCV Viral Evolution After Liver Transplantation
NCT00170131 ·Status: COMPLETED
-
Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects
NCT01473056 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response to Hepatitis C Virus
NCT00165919 ·Status: WITHDRAWN
-
The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
NCT01289652 ·Status: UNKNOWN
-
Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C
NCT00980161 ·Status: UNKNOWN
-
Pharmacogenomic Research in Korean Patients With Hepatitis C
NCT01453244 ·Status: COMPLETED
-
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection
NCT03588923 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects
NCT00696904 ·Status: COMPLETED ·Phase: PHASE1
-
Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects
NCT00807001 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection
NCT01740791 ·Status: COMPLETED ·Phase: PHASE1